Krebs Biochemicals & Industries
61.84
+4.51(+7.87%)
Market Cap₹133.33 Cr
PE Ratio-5.50
IndustryHealthcare
Company Performance:
1D+7.87%
1M+18.90%
6M-12.95%
1Y-14.60%
5Y-45.78%
View Company Insightsright
More news about Krebs Biochemicals & Industries
07Aug 25
Krebs Biochemicals Appoints New MD & CEO, Announces Q1 Results
Krebs Biochemicals & Industries Ltd has appointed Manish Kumar Jain as the new Managing Director and CEO for a five-year term, effective August 7, replacing Jitendra Shah who resigned. The company has also restructured its Audit Committee and Stakeholder Relationship Committee, including Jain in both. The board approved Q1 financial results ending June 30, which were subject to limited review by auditors. These changes comply with SEBI regulations.
 no imag found
07Aug 25
Krebs Biochemicals Announces Q1 Results and Leadership Transition
Krebs Biochemicals & Industries has announced significant changes in its leadership structure alongside its Q1 2025 results. Manish Kumar Jain, a Chartered Accountant with 25 years of experience, has been appointed as the new Managing Director & CEO effective August 7, 2025, replacing Jitendra Shah. The company has also restructured its board committees, including the Audit Committee and Stakeholder Relationship Committee. The unaudited Q1 financial results ending June 30, 2025, were approved by the Board, though specific figures were not disclosed.
 no imag found
25Jul 25
Krebs Biochemicals & Industries' MD & CEO Jitendra Shah Steps Down
Jitendra Shah, Managing Director, CEO, and Director of Krebs Biochemicals & Industries Limited, has announced his resignation effective August 7, 2025, citing personal reasons. The resignation letter was submitted on July 25, 2025. The company has informed BSE Limited and the National Stock Exchange of India Ltd about this development. No successor has been announced yet, with the board expected to address the transition in the upcoming meeting on August 7, 2025.
 no imag found
1 Year Returns:-14.60%
Industry Peers
Sun Pharmaceutical
1,654.90
(-3.62%)
Divis Laboratories
6,116.50
(+2.76%)
Torrent Pharmaceuticals
4,155.20
(+1.48%)
Lupin
2,333.80
(+1.69%)
Dr Reddys Laboratories
1,232.20
(+1.68%)
Cipla
1,229.50
(+0.42%)
Zydus Life Science
915.40
(+1.46%)
Mankind Pharma
2,079.00
(+1.21%)
Aurobindo Pharma
1,349.40
(+0.67%)
Alkem Laboratories
5,440.00
(+1.29%)